Adcentrx
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$13M
Adcentrx Therapeutics is a biotech company developing next-generation Antibody-Drug Conjugate (ADC) therapies for cancer, utilizing its proprietary i-Conjugation™ technology.
Focus Areas
Biotechnology
Antibody-Drug Conjugates
Cancer Therapeutics
Clinical Trials
Proprietary Technology
Targeted Therapies
Investors
